534 related articles for article (PubMed ID: 21699480)
21. Meningiomas in children and adolescents: a meta-analysis of individual patient data.
Kotecha RS; Pascoe EM; Rushing EJ; Rorke-Adams LB; Zwerdling T; Gao X; Li X; Greene S; Amirjamshidi A; Kim SK; Lima MA; Hung PC; Lakhdar F; Mehta N; Liu Y; Devi BI; Sudhir BJ; Lund-Johansen M; Gjerris F; Cole CH; Gottardo NG
Lancet Oncol; 2011 Dec; 12(13):1229-39. PubMed ID: 22094004
[TBL] [Abstract][Full Text] [Related]
22. Stereotactic radiotherapy as primary definitive or postoperative treatment of intracranial meningioma of WHO grade II and III leads to better disease control than stereotactic radiotherapy of recurrent meningioma.
Lubgan D; Rutzner S; Lambrecht U; Rössler K; Buchfelder M; Eyüpoglu I; Fietkau R; Semrau S
J Neurooncol; 2017 Sep; 134(2):407-416. PubMed ID: 28667597
[TBL] [Abstract][Full Text] [Related]
23. Olfactory groove meningioma: discussion of clinical presentation and surgical outcomes following excision via the subcranial approach.
Pepper JP; Hecht SL; Gebarski SS; Lin EM; Sullivan SE; Marentette LJ
Laryngoscope; 2011 Nov; 121(11):2282-9. PubMed ID: 21994142
[TBL] [Abstract][Full Text] [Related]
24. Fractionated stereotactic radiotherapy in patients with benign or atypical intracranial meningioma: long-term experience and prognostic factors.
Milker-Zabel S; Zabel A; Schulz-Ertner D; Schlegel W; Wannenmacher M; Debus J
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):809-16. PubMed ID: 15708260
[TBL] [Abstract][Full Text] [Related]
25. Combined proton and photon conformal radiotherapy for intracranial atypical and malignant meningioma.
Boskos C; Feuvret L; Noel G; Habrand JL; Pommier P; Alapetite C; Mammar H; Ferrand R; Boisserie G; Mazeron JJ
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):399-406. PubMed ID: 19203844
[TBL] [Abstract][Full Text] [Related]
26. Early adjuvant radiotherapy in the treatment of atypical meningioma.
Jenkinson MD; Waqar M; Farah JO; Farrell M; Barbagallo GM; McManus R; Looby S; Hussey D; Fitzpatrick D; Certo F; Javadpour M
J Clin Neurosci; 2016 Jun; 28():87-92. PubMed ID: 26775147
[TBL] [Abstract][Full Text] [Related]
27. Outcomes of WHO Grade I meningiomas receiving definitive or postoperative radiotherapy.
Tanzler E; Morris CG; Kirwan JM; Amdur RJ; Mendenhall WM
Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):508-13. PubMed ID: 20452142
[TBL] [Abstract][Full Text] [Related]
28. Revisiting Adjuvant Radiotherapy After Gross Total Resection of World Health Organization Grade II Meningioma.
Graffeo CS; Leeper HE; Perry A; Uhm JH; Lachance DJ; Brown PD; Ma DJ; Van Gompel JJ; Giannini C; Johnson DR; Raghunathan A
World Neurosurg; 2017 Jul; 103():655-663. PubMed ID: 28450233
[TBL] [Abstract][Full Text] [Related]
29. Determining the role of adjuvant radiotherapy in the management of meningioma: a Surveillance, Epidemiology, and End Results analysis.
Reddy AK; Ryoo JS; Denyer S; McGuire LS; Mehta AI
Neurosurg Focus; 2019 Jun; 46(6):E3. PubMed ID: 31153148
[TBL] [Abstract][Full Text] [Related]
30. Atypical and malignant meningioma: outcome and prognostic factors in 119 irradiated patients. A multicenter, retrospective study of the Rare Cancer Network.
Pasquier D; Bijmolt S; Veninga T; Rezvoy N; Villa S; Krengli M; Weber DC; Baumert BG; Canyilmaz E; Yalman D; Szutowicz E; Tzuk-Shina T; Mirimanoff RO;
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1388-93. PubMed ID: 18294779
[TBL] [Abstract][Full Text] [Related]
31. Outcome and survival following primary and repeat surgery for World Health Organization Grade III meningiomas.
Sughrue ME; Sanai N; Shangari G; Parsa AT; Berger MS; McDermott MW
J Neurosurg; 2010 Aug; 113(2):202-9. PubMed ID: 20225922
[TBL] [Abstract][Full Text] [Related]
32. Malignant meningiomas: a retrospective study of 22 cases.
Liu Y; Liu M; Li F; Wu C; Zhu S
Bull Cancer; 2007 Oct; 94(10):E27-31. PubMed ID: 17964977
[TBL] [Abstract][Full Text] [Related]
33. Atypical meningiomas: is postoperative radiotherapy indicated?
Lee KD; DePowell JJ; Air EL; Dwivedi AK; Kendler A; McPherson CM
Neurosurg Focus; 2013 Dec; 35(6):E15. PubMed ID: 24289123
[TBL] [Abstract][Full Text] [Related]
34. Convexity meningiomas: study of recurrence factors with special emphasis on the cleavage plane in a series of 100 consecutive patients.
Alvernia JE; Dang ND; Sindou MP
J Neurosurg; 2011 Sep; 115(3):491-8. PubMed ID: 21663413
[TBL] [Abstract][Full Text] [Related]
35. Parasagittal meningiomas: follow-up review.
Colli BO; Carlotti CG; Assirati JA; Dos Santos MB; Neder L; Dos Santos AC
Surg Neurol; 2006; 66 Suppl 3():S20-7; discussion S27-8. PubMed ID: 17081848
[TBL] [Abstract][Full Text] [Related]
36. Atypical and malignant meningiomas: Considerations for treatment and efficacy of radiotherapy.
Cain SA; Smoll NR; Van Heerden J; Tsui A; Drummond KJ
J Clin Neurosci; 2015 Nov; 22(11):1742-8. PubMed ID: 26213286
[TBL] [Abstract][Full Text] [Related]
37. Atypical Meningiomas: Recurrence, Reoperation, and Radiotherapy.
Klinger DR; Flores BC; Lewis JJ; Hatanpaa K; Choe K; Mickey B; Barnett S
World Neurosurg; 2015 Sep; 84(3):839-45. PubMed ID: 25916182
[TBL] [Abstract][Full Text] [Related]
38. Multimodal treatment of parasagittal meningiomas: a single-center experience.
Gatterbauer B; Gevsek S; Höftberger R; Lütgendorf-Caucig C; Ertl A; Mallouhi A; Kitz K; Knosp E; Frischer JM
J Neurosurg; 2017 Dec; 127(6):1249-1256. PubMed ID: 28156245
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of radiotherapy and stereotactic radiosurgery as adjuvant or salvage treatment in atypical and anaplastic (WHO grade II and III) meningiomas: a systematic review and meta-analysis.
Gagliardi F; De Domenico P; Snider S; Pompeo E; Roncelli F; Barzaghi LR; Acerno S; Mortini P
Neurosurg Rev; 2023 Mar; 46(1):71. PubMed ID: 36928326
[TBL] [Abstract][Full Text] [Related]
40. Treatment of atypical meningioma.
Jo K; Park HJ; Nam DH; Lee JI; Kong DS; Park K; Kim JH
J Clin Neurosci; 2010 Nov; 17(11):1362-6. PubMed ID: 20800497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
